Haisco Pharmaceutical describes new IL-17A production inhibitors
Haisco Pharmaceutical Group Co. Ltd. has identified IL-17A production inhibitors with reduced toxic and side effects. Read More
Haisco Pharmaceutical Group Co. Ltd. has identified IL-17A production inhibitors with reduced toxic and side effects. Read More
Amplo Biotechnology Inc. has been awarded a fast track phase I/II Small Business Technology Transfer (STTR) grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Read More
Nectin cell adhesion molecule 4 (Nectin-4) overexpression in different tumors correlates with cancer progression and poor prognosis in many human malignancies. The first Nectin-4-targeting antibody, enfortumab vedotin (EV), has Read More
Renal denervation (RDN) was described as the “comeback kid” at the recent EuroPCR conference in Paris where participants argued that following the success seen in several sham-controlled trials, there Read More
Exact Sciences Corp.’s long-term analysis of results from the Detecting cancers Earlier Through Elective mutation-based blood Collection and Testing (DETECT-A) study found that all patients diagnosed and treated for Read More
A preview of the next edition of BioWorld, May 26, 2023 Read More
BioWorld MedTech presents Patent Highlights, an excerpt of the most important med-tech patents from this week's Cortellis Patents Gazette. Read More
Year-to-date money raised in public, private and other financings of biopharma companies. Read More
The U.K. government has announced £121 million (US$148 million) in funding to reboot the commercial clinical trials system after a sharp decline saw the number of industry-sponsored studies falling Read More